Search Within

Brian Kushner

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (38)
  2. Meeting Abstract (15)
  3. Conference Paper (2)
Groups
  1. Epidemiology and Biostatistics (55)
  2. Neuroblastoma Service (55)
  3. Pediatrics, Department of (55)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (52)
  5. GSK Faculty (52)
  6. Tow Center for Developmental Oncology (TCDO) (52)

More Groups

People
  1. Nai-Kong Cheung (50)
  2. Shakeel Modak (33)
  3. Kim Kramer (28)
  4. Irene Cheung (21)
  5. Ellen Basu (20)
  6. Stephen Roberts (18)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (3)
  4. 2022 (3)
  5. 2021 (4)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (15)
  2. Pediatric Blood and Cancer (13)
  3. Cancer (5)
  4. Cancer Research (3)
  5. Medical and Pediatric Oncology (3)
  6. OncoImmunology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. Wiley Periodicals, Inc (13)
  3. American Association for Cancer Research (5)
  4. Wiley Blackwell (5)
  5. Landes Bioscience (3)
  6. Wiley Liss (3)

More Publishers

Results (55)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte- macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission
    Journal Article

    Cheung, N. K. V.; Cheung, I. Y.; Kushner, B. H.; Ostrovnaya, I.; Chamberlain, E.; Kramer, K.; Modak, S.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastoma
    Journal Article

    Kushner, B. H.; Kramer, K.; Modak, S.; Qin, L. X.; Cheung, N. K. V.
    Cancer (2010)

    Fulltext@MSK | Save
  • Hypothyroidism after 131I-monoclonal antibody treatment of neuroblastoma
    Journal Article

    Bhandari, S.; Cheung, N. K. V.; Kushner, B. H.; Kramer, K.; Modak, S.; Larson, S. M.; Yeh, S.; Heller, G.; Sklar, C. A.
    Pediatric Blood and Cancer (2010)

    Fulltext@MSK | Save
  • Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma
    Journal Article

    Kushner, B. H.; Kramer, K.; Modak, S.; Qin, L. X.; Yataghene, K.; Jhanwar, S. C.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2009)

    Fulltext@MSK | Save
  • Phase I study of the combination of anti-GD2 antibody 3F8 and barley-derived (1→3,1→4)-ß-D-glucan for patients with resistant neuroblastoma
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Kramer, K.; Vickers, A.; Cheung, N.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I study of the combination of anti-GD2 antibody 3F8 and barley-derived beta glucan for resistant neuroblastoma
    Meeting Abstract

    Modak, S.; Kushner, B.; Kramer, K.; Vickers, A.; Cheung, N. K.
    Pediatric Blood and Cancer (2007)

    Fulltext@MSK | Save
  • FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor
    Journal Article

    Cheung, N. K. V.; Sowers, R.; Vickers, A. J.; Cheung, I. Y.; Kushner, B. H.; Gorlick, R.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • The impact of gross total resection on local control and survival in high-risk neuroblastoma
    Journal Article

    La Quaglia, M. P.; Kushner, B. H.; Su, W.; Heller, G.; Kramer, K.; Abramson, S.; Rosen, N.; Wolden, S.; Cheung, N. K. V.
    Journal of Pediatric Surgery (2004)

    Fulltext@MSK | Save
  • Treatment of spinal involvement in neuroblastoma patients
    Journal Article

    Sandberg, D. I.; Bilsky, M. H.; Kushner, B. H.; Souweidane, M. M.; Kramer, K.; LaQuaglia, M. P.; Panageas, K. S.; Cheung, N. K. V.
    Pediatric Neurosurgery (2003)

    Fulltext@MSK | Save
  • N7: A novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age
    Journal Article

    Cheung, N. K. V.; Kushner, B. H.; Laquaglia, M.; Kramer, K.; Gollamudi, S.; Heller, G.; Gerald, W.; Yeh, S.; Finn, R.; Larson, S. M.; more...
    Medical and Pediatric Oncology (2001)

    Fulltext@MSK | Save